Eurofins Scientific SE (ERFSF)
USD 64.5
(-0.77%)
USD 64.5
(-0.77%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 139 Million EUR | -4.53% |
| 2022 | 145.6 Million EUR | -5.58% |
| 2021 | 154.2 Million EUR | -1.78% |
| 2020 | 157 Million EUR | 97.98% |
| 2019 | 79.3 Million EUR | 19.48% |
| 2018 | 66.37 Million EUR | 28.12% |
| 2017 | 51.8 Million EUR | 31.0% |
| 2016 | 39.54 Million EUR | 5.42% |
| 2015 | 37.51 Million EUR | 52.36% |
| 2014 | 24.62 Million EUR | 22.25% |
| 2013 | 20.14 Million EUR | 45.28% |
| 2012 | 13.86 Million EUR | 39.35% |
| 2011 | 9.94 Million EUR | 18.6% |
| 2010 | 8.38 Million EUR | 7.98% |
| 2009 | 7.76 Million EUR | 1.57% |
| 2008 | 7.64 Million EUR | -69.11% |
| 2007 | 24.76 Million EUR | 45.27% |
| 2006 | 17.04 Million EUR | 80.76% |
| 2005 | 9.43 Million EUR | 32.67% |
| 2004 | 7.1 Million EUR | 1.59% |
| 2003 | 6.99 Million EUR | 0.3% |
| 2002 | 6.97 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 142.4 Million EUR | 0.0% |
| 2023 Q4 | 139 Million EUR | 0.0% |
| 2023 FY | 139 Million EUR | -4.53% |
| 2023 Q2 | 150.3 Million EUR | 0.0% |
| 2022 Q4 | 145.6 Million EUR | 0.0% |
| 2022 Q2 | 159.2 Million EUR | 0.0% |
| 2022 FY | 145.6 Million EUR | -5.58% |
| 2021 Q2 | 169.1 Million EUR | 0.0% |
| 2021 FY | 154.2 Million EUR | -1.78% |
| 2021 Q4 | 154.2 Million EUR | 0.0% |
| 2020 Q2 | 123.9 Million EUR | 0.0% |
| 2020 FY | 157 Million EUR | 97.98% |
| 2020 Q4 | 157 Million EUR | 0.0% |
| 2019 Q4 | 79.3 Million EUR | 0.0% |
| 2019 Q2 | 74.41 Million EUR | 0.0% |
| 2019 FY | 79.3 Million EUR | 19.48% |
| 2018 Q4 | 66.37 Million EUR | 0.0% |
| 2018 FY | 66.37 Million EUR | 28.12% |
| 2018 Q2 | 53.19 Million EUR | 0.0% |
| 2017 Q2 | 40.08 Million EUR | 0.0% |
| 2017 Q4 | 51.8 Million EUR | 0.0% |
| 2017 FY | 51.8 Million EUR | 31.0% |
| 2016 Q2 | 38.6 Million EUR | 0.0% |
| 2016 Q4 | 39.54 Million EUR | 0.0% |
| 2016 FY | 39.54 Million EUR | 5.42% |
| 2015 Q2 | 28.13 Million EUR | 0.0% |
| 2015 FY | 37.51 Million EUR | 52.36% |
| 2015 Q4 | 37.51 Million EUR | 0.0% |
| 2014 FY | 24.62 Million EUR | 22.25% |
| 2014 Q4 | 24.62 Million EUR | 0.0% |
| 2014 Q2 | 23.65 Million EUR | 0.0% |
| 2013 Q2 | 19.87 Million EUR | 0.0% |
| 2013 FY | 20.14 Million EUR | 45.28% |
| 2013 Q4 | 20.14 Million EUR | 0.0% |
| 2012 Q2 | 10.99 Million EUR | 0.0% |
| 2012 Q4 | 13.86 Million EUR | 0.0% |
| 2012 FY | 13.86 Million EUR | 39.35% |
| 2011 Q3 | 8.72 Million EUR | 1.35% |
| 2011 Q4 | 9.94 Million EUR | 14.04% |
| 2011 Q1 | 8.07 Million EUR | -3.7% |
| 2011 Q2 | 8.6 Million EUR | 6.55% |
| 2011 FY | 9.94 Million EUR | 18.6% |
| 2010 FY | 8.38 Million EUR | 7.98% |
| 2010 Q4 | 8.38 Million EUR | 2.01% |
| 2010 Q2 | 8.08 Million EUR | 1.42% |
| 2010 Q1 | 7.97 Million EUR | 2.63% |
| 2010 Q3 | 8.22 Million EUR | 1.71% |
| 2009 Q4 | 7.76 Million EUR | 0.0% |
| 2009 FY | 7.76 Million EUR | 1.57% |
| 2008 FY | 7.64 Million EUR | -69.11% |
| 2007 FY | 24.76 Million EUR | 45.27% |
| 2006 FY | 17.04 Million EUR | 80.76% |
| 2005 FY | 9.43 Million EUR | 32.67% |
| 2004 FY | 7.1 Million EUR | 1.59% |
| 2003 FY | 6.99 Million EUR | 0.3% |
| 2002 FY | 6.97 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | -36575.462% |
| Arrayit Corporation | 464.19 Thousand USD | -29844.506% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | -18261.955% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 5828192.243% |
| DermTech, Inc. | 1 Million USD | -13744.622% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | -4113.256% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | -15186.013% |
| iMD Companies, Inc. | 38.31 Thousand USD | -362672.732% |
| IDenta Corp. | 442.28 Thousand USD | -31327.984% |
| Interpace Biosciences, Inc. | 1.22 Million USD | -11228.443% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -85105.505% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | -17629.592% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 37066766.667% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | -29551.815% |
| PharmChem, Inc. | 391.93 Thousand USD | -35364.883% |
| Proteome Sciences plc | 1.06 Million USD | -12945.506% |
| Response Genetics, Inc | 133 Thousand USD | -104411.278% |
| Rennova Health, Inc. | 242.64 Thousand USD | -57185.335% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -187999.652% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -145265.558% |
| Todos Medical Ltd. | 1.02 Million USD | -13514.117% |